KLI

Login OAK 국가리포지터리

검색

Ulsan Univ. Repository Journal Papers Medicine Nursing

Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma

1
2
3
4
5

Metadata Downloads

Abstract: Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma

Issued Date: 2022

Type: Article

Keyword: Adverse events of special interest; Durvalumab; Fixed dose; Immune checkpoint inhibitor; Immune-mediated adverse events; Immune-related adverse events; Overall survival; PD-L1; Urinary tract carcinoma; Urothelial carcinoma.

DOI: 10.1016/j.ejca.2021.12.012

URI: https://oak.ulsan.ac.kr/handle/2021.oak/14131

Publisher: EUROPEAN JOURNAL OF CANCER

Language: 영어

ISSN: 0959-8049

Citation Volume: 163

Citation Number: 0

Citation Start Page: 55

Citation End Page: 65

Appears in Collections:: Medicine > Nursing

Show Simple Item RecordShow Full Item Record

Authorize & License

Authorize공개

qrcode

트윗하기

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

OAK Ulsan Univ. Repository was built as a OAK to the National Central Library.

Anonymous

Login

Guide